Related Experiment Video
Updated: Jan 2, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Prognostic Value of Late Gadolinium Enhancement in Postoperative Morbidity following Mitral Valve Surgery in
Teuku Muhammad Haykal Putra1, Renan Sukmawan1, Elen Elen1
1Department of Cardiology and Vascular Medicine, Division of Nuclear Cardiology and Cardiovascular Imaging, Faculty of Medicine, Universitas Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia.
Abstract:
Myocardial fibrosis in rheumatic mitral stenosis (MS) is caused by chronic inflammatory process. Its occurrence may lead to hemodynamic problems, especially after cardiac surgery. Myocardial fibrosis predicts worse morbidity after cardiac surgery, notably in coronary heart disease and aortic valve abnormalities. However, this issue has not been explored yet among patients with rheumatic MS. The aim of the study was to investigate prognostic impact of myocardial fibrosis to postoperative morbidity after mitral valve surgery in patients with rheumatic MS. This is a prospectively enrolled observational study of 47 consecutive rheumatic MS patients. All patients had preoperative evaluation with cardiac magnetic resonance imaging (CMR) including late gadolinium enhancement (LGE) protocol for left ventricular myocardial fibrosis assessment prior to mitral valve surgery. All patients were followed during hospitalization period. Postoperative morbidities were defined as stroke, renal failure, and prolonged mechanical ventilation. This study involved 33 women (70.2%) and 14 men (29.8%) with a mean age of 46 ± 10 years. Preoperative myocardial fibrosis was identified in 43 patients (91.5%). Estimated fibrosis volume ranged from 0% to 12.8% (median 2.8%). Postoperative morbidities occurred in 11 patients (23.4%). Significant mean difference of myocardial fibrosis volume was observed between patients with and without morbidity after mitral valve surgery (5.97 ± 4.16% and 3.12 ± 2.62%, p = 0.04). This significant association was allegedly influenced by different postoperative hemodynamic changes between the two groups. More extensive myocardial fibrosis is associated with postoperative morbiditiy after mitral valve surgery in patients with rheumatic MS.
Insights
Myocardial fibrosis, a scarring of heart muscle, is common in rheumatic mitral stenosis patients undergoing valve surgery. Higher fibrosis levels correlate with increased postoperative complications, highlighting its prognostic significance.
Area of Science:
- Cardiology
- Cardiac Surgery
- Medical Imaging
Background:
- Rheumatic mitral stenosis (MS) involves chronic inflammation leading to myocardial fibrosis.
- Myocardial fibrosis is a known predictor of adverse outcomes in various cardiac conditions.
- The prognostic impact of myocardial fibrosis in rheumatic MS patients undergoing mitral valve surgery remains underexplored.
Purpose of the Study:
- To investigate the prognostic value of myocardial fibrosis in predicting postoperative morbidity after mitral valve surgery in patients with rheumatic MS.
Main Methods:
- Prospective observational study of 47 consecutive rheumatic MS patients.
- Preoperative cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement (LGE) assessed left ventricular myocardial fibrosis.
- Patients were monitored for postoperative morbidities including stroke, renal failure, and prolonged mechanical ventilation.
Main Results:
- Preoperative myocardial fibrosis was detected in 91.5% of patients, with a median fibrosis volume of 2.8%.
- Postoperative morbidities occurred in 23.4% of patients.
- A significant association was found between higher myocardial fibrosis volume and increased postoperative morbidity (5.97% vs. 3.12%, p=0.04).
Conclusions:
- Extensive myocardial fibrosis is linked to a higher risk of postoperative morbidity in rheumatic MS patients undergoing mitral valve surgery.
- Myocardial fibrosis assessment may aid in risk stratification for these patients.
- Further research is warranted to elucidate the mechanisms linking fibrosis to adverse outcomes.
More Related Videos
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis IV: Nursing Management

